Denis Carniato

USPTO Granted Patents = 50 (Patent Applications = 4)

CIPO Patents = 10 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 6.5

ph-index = 8

Forward Citations = 200(Granted Patents)

Forward Citations (Not Self Cited) = 193(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Clamart, FR (1994 - 2002)
F 06800 Cagnes sur Mer, FR (2003)
Cagnes Sur Mer, FR (2001 - 2008)
Antony, FR (2013)
Marcoussis, FR (1999 - 2020)

Company Filing History:

Hoechst Aktiengesellschaft

Centre National De La Recherche Scientifique

patents

7. 3 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

Hoechst Marion Roussel

patents

10. 1 out of 66

Hoechst Japan Limited

13. 22 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2020

Loading Chart...

Areas of Expertise:

Indole Derivatives

Piperazinyl Derivatives

Imidazole Derivatives

Thiazole Derivatives

Cycloalkyl Derivatives

Aromatase Inhibitors

Guanidine Derivatives

Vitronectin Receptor Antagonists

Bone Resorption Inhibitors

Sulfonamide Derivatives

Tricyclic Compounds

Antimicrobial Agents

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10851054 - Derivatives of indole for the treatment of cancer, viral infections and lung diseases (2020-12-01),

2. 10308683 - Bicyclic lipolantipeptide, preparation and use as antimicrobial agent (2019-06-04),

3. 10189782 - Derivatives of indole for the treatment of cancer, viral infections and lung diseases (2019-01-29),

4. 9877962 - Piperazinyl derivatives for the treatment of cancer (2018-01-30),

5. 9643923 - Derivatives of indole for the treatment of cancer, viral infections and lung diseases (2017-05-09),

6. 9321778 - Piperazinyl derivatives for the treatment of cancer (2016-04-26),

7. 8673955 - Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them (2014-03-18),

8. 8586577 - Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors (2013-11-19),

9. 8546575 - NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 (2013-10-01),

10. 8519188 - Compounds which can be used for the treatment of cancers (2013-08-27),

11. 8486964 - Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors (2013-07-16),

12. 8470849 - 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors (2013-06-25),

13. 8466200 - 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors (2013-06-18),

14. 8242107 - Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors (2012-08-14),

15. 8236824 - N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators (2012-08-07),

Title: The Innovative Contributions of Denis Carniato

Introduction

Denis Carniato, located in Marcoussis, France, is a prolific inventor with a remarkable portfolio of 50 patents. His work primarily focuses on developing innovative therapeutic agents, showcasing his commitment to advancing medical science.

Latest Patents

Carniato's latest contributions to innovation include two significant patents. The first is titled "Derivatives of indole for the treatment of cancer, viral infections and lung diseases." This invention introduces a new class of indole derivatives that exhibit a unique MKlp2 inhibition profile, positioning them as promising therapeutic agents for tackling cancer, viral infections, and lung conditions. The second patent, "Bicyclic lipolantipeptide, preparation and use as antimicrobial agent," pertains to a novel bicyclic lipolantipeptide. This new class of lantipeptide is useful as an antimicrobial agent in preventing and treating infections across humans, animals, and plants.

Career Highlights

Throughout his career, Carniato has made significant contributions while working at notable companies such as Merck Patent GmbH. His dedication to research and innovation has solidified his position as a leading figure in his field, focusing on the development of groundbreaking therapeutic solutions.

Collaborations

Denis has collaborated with esteemed professionals in the industry, including Jochen Knolle and Jean-Francois Gourvest. These partnerships have enriched his work and fostered an environment of shared knowledge and innovation.

Conclusion

In conclusion, Denis Carniato's influential patents and collaborative efforts mark him as a noteworthy inventor in the medical research domain. His commitment to innovation continues to pave the way for advancements in the treatment of critical health issues, reinforcing the vital role of inventors in enhancing human health and well-being.

This text is generated by artificial intelligence and may not be accurate.